The Joseph E. and Marjorie B. Jones Foundation from Washington, DC and BioSciCon, Inc., Rockville, Maryland, USA were sponsors of the Global Academy for Women’s Health.

The Jones Foundation is a private, philanthropic institution dedicated to improving the quality of life for all people, particularly those residing in Washington metropolitan area, by funding medical research, supporting human services and healthcare, and furthering the cause of education [Foundation Mission Statement].

The Jones Foundation provided a grant for the Advancement in Education and Science for Women’s Health initiative. The grant was used for preparation of a book “What every women should know about cervical cancer,” which is currently under contract with an international publisher for issuance in 2008. A part of the grant was used for presentation of new results from the ongoing research on cervical cancer prevention and control at the Annual Meeting of the American Society for Cytopathology—the professional organization directly involved in cervical cancer control. The Global Academy for Women's Health gratefully acknowledges this support of the Jones Foundation.

BioSciCon, the Biomedical Science Consulting, Inc. was created as a consulting company with educational, research and regulatory interest in the field of women's health, particularly cervical cancer where the founder had a patent for a new biomarker based test. Through years, the R&D activity was separated and expanded. The non-profit activity concentrated in education and research for public benefit is now integrated and deferred to care of the Academy. The Academy integrates prior extensive BioSciCon non-profit efforts and continues its legacy to save women’s lives.

During the last ten years BioSciCon has focused its activities on the development of the proprietary biomarker-based, MarkPap® technology products aimed for improving the quality of women’s lives by providing means to relive women from the well justified fear of dying from cervical cancer. The emerging biomarker technology provides opportunity for development of multiple devices with many advantages in comparison with the current standard medical practice. This process incites a huge individual and collective intellectual effort, which creates new information for the protection and promotion of women's health. This “science for public benefit” research guarantees a continuous source of inspiring ideas for the mission of the Academy.